Document:

EX-10.2

 Exhibit 10.2 

EXECUTION VERSION 

GOVERNANCE AGREEMENT 
 by
and between 
 SEARCHLIGHT III CVL, L.P. 

and 
 CONSOLIDATED COMMUNICATIONS
HOLDINGS, INC. 
 Dated as of September 13, 2020 
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
			
	 Section 1
	 	Definitions	  	 	1	 
			
	 Section 2
	 	Board Composition	  	 	4	 
			
	 Section 3
	 	Committee Membership	  	 	5	 
			
	 Section 4
	 	Compensation and Benefits	  	 	6	 
			
	 Section 5
	 	Corporate Opportunities	  	 	6	 
			
	 Section 6
	 	Special Approval Matters	  	 	6	 
			
	 Section 7
	 	Restrictions on Transfer	  	 	7	 
			
	 Section 8
	 	Standstill Restrictions	  	 	9	 
			
	 Section 9
	 	Preemptive Rights	  	 	9	 
			
	 Section 10
	 	Books and Records; Access	  	 	10	 
			
	 Section 11
	 	Section 16b-3	  	 	11	 
			
	 Section 12
	 	Confidentiality	  	 	11	 
			
	 Section 13
	 	No Inconsistent Agreements; Additional Rights	  	 	12	 
			
	 Section 14
	 	Governing Law	  	 	12	 
			
	 Section 15
	 	Specific Enforcement; Jurisdiction	  	 	12	 
			
	 Section 16
	 	Successors and Assigns	  	 	13	 
			
	 Section 17
	 	No Third-Party Beneficiaries	  	 	13	 
			
	 Section 18
	 	Entire Agreement	  	 	13	 
			
	 Section 19
	 	Notices	  	 	13	 
			
	 Section 20
	 	Delays or Omissions	  	 	14	 
			
	 Section 21
	 	Amendments and Waivers	  	 	14	 
			
	 Section 22
	 	Counterparts	  	 	14	 
			
	 Section 23
	 	Severability	  	 	14	 
			
	 Section 24
	 	Titles and Subtitles; Interpretation	  	 	14	 

  

  
 i 

 GOVERNANCE AGREEMENT 

This GOVERNANCE AGREEMENT (this “Agreement”), dated as of September 13, 2020, by and between Consolidated
Communications Holdings, Inc., a Delaware corporation (the “Company”), Searchlight III CVL, L.P., a Delaware limited partnership (the “Investor”). 

WHEREAS, on the date hereof, the Company and the Investor entered into an Investment Agreement (the “Investment Agreement”),
pursuant to which the Company agreed to sell, and the Investor agreed to purchase, for an aggregate consideration of up to $425,000,000, (a) shares of common stock of the Company, par value $0.01 per share (the “Common Stock”), (b)
an unsecured senior note with an aggregate principal amount of $425,000,000, which shall initially be non-convertible, but which shall, upon the occurrence of certain events, be convertible at the option of
the Investor, or if the Investor fails to exercise its option, at the option of the Company, into shares of a new series of preferred stock, par value $0.01 of the Company, to be designated the Company’s Series A Perpetual Preferred Stock, par
value $0.01 per share (the “Series A Preferred Stock”) and (c) a Contingent Payment Right (as defined in the Investment Agreement), which shall be automatically converted into shares of Common Stock subject to the terms and
conditions of the Contingent Payment Right Agreement (as defined in the Investment Agreement); and 
 WHEREAS, the Investment Agreement
provides for this Agreement to be entered into on the date of the Investment Agreement and effective at the Initial Closing (as defined in the Investment Agreement) (the “Effective Date”). 

NOW, THEREFORE, in consideration of the foregoing and the agreements contained in this Agreement, and intending to be legally bound by this
Agreement, the Company and the Investor agree as follows: 
 Section 1 Definitions. Capitalized
terms used and not otherwise defined in this Agreement shall have the respective meanings given such terms in the Investment Agreement. As used in this Agreement, the following terms shall have the respective meanings set forth in this
Section 1: 
 “affiliate” of a specified person shall mean a person who, directly or indirectly
through one or more intermediaries, controls, is controlled by, or is under common control with, such specified person; provided that, with respect to the Investor and its affiliates, “affiliate” shall include any entity that is
managed by Searchlight Capital Partners, L.P. (“SCP”) and such entities’ respective affiliates (except for any portfolio company or investment fund affiliated with SCP, other than for purposes of
Section 5 (Corporate Opportunities), Section 7(b)(v) (Restrictions on Transfer), Section 9(b) (Preemptive Rights) and Section 12
(Confidentiality), the definition of Permitted Holder or for purposes of uses of the term “Representatives” with respect to the Investor and its affiliates); provided, further, that the Investor and its affiliates shall be
deemed not to be an affiliate of the Company or any of its Subsidiaries. For purposes of this definition, the term “control” (including the correlative terms “controlling,” “controlled by” and “under common control
with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 

  
 1 

 “As-Converted Basis” means assuming
that the Contingent Payment Right has been converted into shares of Common Stock pursuant to the Contingent Payment Right Agreement, regardless of whether it has actually been so converted at such time. 

“As-Converted Common Stock Ownership Percentage” means, as of any date, the
percentage equal to (i) the aggregate number of shares of Common Stock that the Investor and any Permitted Holders beneficially own (calculated on an As-Converted Basis) divided by (ii) the
total number of shares of Common Stock then outstanding (calculated on an As-Converted Basis). 

“Board” means the Board of Directors of the Company. 

“Business Day” means a day except a Saturday, a Sunday or other day on which banks in the City of New York are authorized or
required by applicable law to be closed. 
 “Certificate of Designations” means the Certificate of Designations of the
Series A Preferred Stock. 
 “Common Stock” shall have the meaning set forth in the preamble of this Agreement. 

“Company” shall have the meaning set forth in the preamble of this Agreement. 

“Company Charter Documents” means the Company’s Certificate of Incorporation and
By-Laws, each as amended to the date of this Agreement, and shall include the Certificate of Designations, as filed with the Secretary of State of the State of Delaware. 

“Confidential Information” means any and all non-public information concerning the
Company that has been or is furnished to the Investor (regardless of the manner in which it is furnished, including without limitation in written or electronic format or orally, gathered by visual inspection or otherwise) by or on behalf of the
Company, together with the portions of any documents created by the Investor or its Representatives that contain such information, other than information that (i) is or has become generally available to the public other than as a result of a
direct or indirect disclosure by the Investor or its Representatives in violation of this Agreement, (ii) was within the Investor’s or any of its Representatives’ possession prior to its being furnished to the Investor by or on behalf
of the Company, (iii) is received from a source other than the Investor or any of its representatives; provided, that in the case of each of (ii) and (iii) above, the source of such information was not known, after reasonable
investigation, by the Investor to be bound by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the Company with respect to such information at the time the same was disclosed, or (iv) is
independently developed by the Investor or any of its Representatives without breach of this Agreement. 
 “Effective Date”
shall have the meaning set forth in the recitals of this Agreement. 
 “Equity-Linked Securities” means any security or
instrument convertible into, exercisable or exchangeable for capital stock of the Company. 
 “Exchange Act” means the
Securities Exchange Act of 1934, as amended. 

  
 2 

 “Investment Agreement” shall have the meaning set forth in the recitals of
this Agreement. 
 “Investor” shall have the meaning set forth in the preamble of this Agreement. 

“Investor Board Observer” means an Investor Designee who was appointed as a
non-voting observer of the Board. 
 “Investor Designee” shall mean any individual
that the Investor is entitled to nominate as a director or appoint as an Investor Board Observer. 
 “Investor Parties”
shall have the meaning set forth in Section 5(a). 
 “Nominee Disclosure Information” shall have
the meaning set forth in Section 2(b). 
 “Permitted Holders” means (i) the Investor’s
affiliates and any partners, members or other equityholders of the Investor or any such affiliates, and the respective affiliates of the foregoing, (ii) any successor entity of the Investor or any Person described in the foregoing clause (i)
(for the purposes of subclause (i) and (ii) of this definition, excluding any portfolio company affiliated with the Investor), and (iii) any Person consented to in writing by the Company. 

“Permitted Transfers” shall have the meaning set forth in Section 7(b). 

“Person” shall have the meaning set forth in the Investment Agreement. 

“Preemptive Rights Cap Amount” means, with respect to a Preemptive Rights Issuance, a number of securities which, if divided
by the sum of (i) such number of securities plus (ii) the number of securities issued in such Preemptive Rights Issuance, would represent a percentage that is equal to the As-Converted Common Stock
Ownership Percentage (as of immediately prior to the Preemptive Rights Issuance). 
 “Preemptive Rights Issuance” shall
have the meaning set forth in Section 9(a). 
 “Preemptive Rights Notice” shall have the meaning
set forth in Section 9(b). 
 “Pro Rata Transaction” shall have the meaning set forth in
Section 7(c). 
 “Representatives” means the Permitted Holders and the Investor and each
Permitted Holder’s respective employees, officers, directors, advisors, consultants and other representatives; provided, that no investment fund or portfolio company of SCP will have any obligation as a Representative pursuant to this
Agreement unless and until the Investor furnishes Confidential Information to such investment fund or portfolio company. 

“SEC” means the Securities and Exchange Commission. 

“Series A Preferred Stock” means the Company’s Series A Perpetual Preferred Stock, par value $0.01 per share. 

  
 3 

 “Subsidiary” shall mean any company, partnership, limited liability
company, joint venture, joint stock company, trust, unincorporated organization or other entity at least 50% of the voting capital stock of which is owned, directly or indirectly, by the Company. 

“Transfer” shall have the meaning set forth in Section 7(a). 

Section 2 Board Composition. 

(a) The Investor Designees to be appointed as of the Effective Date and upon receipt of FCC Approval will consist of the individuals set forth
on Exhibit A hereto; provided, that if any such individual is unwilling or unable to serve as an Investor Designee at such time, the Investor may replace such person between the date hereof and the Effective Date or the
date of FCC Approval, as applicable, with any other person that is permitted to be an Investor Designee pursuant to this Section 2(a). After the Effective Date, (i) for so long as the Investor’s As-Converted Common Stock Ownership Percentage is at least 10%, the Investor shall be entitled to nominate one (1) Investor Designee to the Board (provided, that after the receipt of FCC Approval, for so long
as the Investor’s As-Converted Common Stock Ownership Percentage is at least 20%, the Investor shall be entitled to nominate two (2) Investor Designees to the Board), and (ii) for so long as the
Investor’s As-Converted Common Stock Ownership Percentage is at least 5%, the Investor shall be entitled to appoint one (1) additional Investor Designee as an Investor Board Observer to the Board.
The Investor Board Observer shall be permitted to attend, strictly as an observer, meetings of the Board and material information delivered to the Board shall be delivered to the Investor Board Observer at substantially the same time as delivered to
other non-executive directors; provided, however, that the Company shall have the right to withhold any information and to exclude the Investor Board Observer from all or any portion of
any meeting of the Board, or any committee thereof, if access to such information or attendance at such meeting or portion of a meeting could reasonably be expected to (i) materially jeopardize the attorney-client privilege or work product
protection or (ii) violate any applicable law. The Investor Board Observer shall not have any voting rights with respect to any matters considered or determined by the Board or any committee thereof. Any action taken by the Board at any meeting
will not be invalidated by the absence of the Investor Board Observer at such meeting. The Company shall, at any annual or special meeting of stockholders of the Company or action by written consent at which directors are to be elected, subject to
the fulfillment of the requirements set forth in Section 2(b), nominate the Investor Designees (other than any Investor Board Observers) for election to the Board and use all reasonable efforts to cause such Investor
Designees to be elected as directors. In connection therewith, the Board shall recommend that the holders of the Common Stock vote in favor of such Investor Designees and shall support such Investor Designees in a manner no less rigorous and
favorable than the manner in which the Company supports the Board’s other nominees. 
 (b) Any Investor Designee shall be subject to
the Company’s corporate governance guidelines, code of business conduct and ethics and confidentiality and trading policies and guidelines, in each case as in effect and generally applicable to all Board members from time to time. The Investor
shall notify the Company of any proposed Investor Designee in writing no later than the latest date on which stockholders of the Company may make nominations to the Board in accordance with the Bylaws, together with all information concerning such
nominee required to be delivered to the Company by the Bylaws and such other information reasonably requested by the Company; provided that in each such case, all such information is generally required to be

  
 4 

 
delivered to the Company by the other outside directors of the Company (the “Nominee Disclosure Information”); provided, further that in the event the Investor
fails to provide any such notice, the Investor Designees shall be the persons then serving as the Investor Designees as long as the Investor provides the Nominee Disclosure Information to the Company promptly upon request by the Company. 

(c) In the event that there is a vacancy in any Investor Designee’s seat on the Board, whether due to death, disability, resignation,
failure to be elected, removal or any other cause, the Board will promptly elect to the Board a director designated by the Investor, subject to the fulfillment of the requirements set forth in Section 2(a), to fill the
resulting vacancy, and such individual shall then be deemed an Investor Designee for all purposes under this Agreement. 
 (d) So long as
the Investor is exercising its right to have an Investor Designee to the Board, the Investor shall, and shall (to the extent necessary to comply with this Section 2(d)) cause its affiliates that hold shares of Common Stock,
at each meeting of the stockholders of the Company and at every postponement or adjournment thereof, to vote, withhold or abstain with respect to all of the shares of Common Stock beneficially owned by such Investor and entitled to vote at such
meeting of stockholders with respect to the election of any director nominee that is not an Investor Designee in the same proportion as the stockholders of the Company other than the Investor vote, withhold or abstain with respect to each such
director nominee; provided, that such director nominee complies with the requirements applicable to Investor Designees set forth in Section 2(e) below, mutatis mutandis. In furtherance of the foregoing, Investor
shall, and shall (to the extent necessary to comply with this Section 2(d)) cause its affiliates that hold shares of Common Stock to, be present, in person or by proxy, at all meetings of the stockholders of the Company so that all shares of
Common Stock beneficially owned by the Investor and entitled to vote at such meeting of stockholders may be counted for the purposes of determining the presence of a quorum and voted in accordance with this Section 2(d) at
such meetings (including at any adjournments or postponements thereof). 
 (e) The Company’s obligations to have any Investor Designee
appointed to the Board or nominate and recommend any Investor Designee for election as a director at any meeting of the Company’s stockholders pursuant to this Section 2 shall be subject to such Investor Designee’s satisfaction
of all requirements regarding service as a director of the Company under applicable Law and stock exchange rules regarding service as a director of the Company and all other criteria and qualifications for service as a director applicable to all
directors of the Company. The Investor Parties will cause any Investor Designee to be nominated for election to the Board to make himself or herself reasonably available for interviews and to consent to such reference and background checks or
other investigations as the Board may reasonably request to determine such Investor Designee’s eligibility and qualification to serve as a director of the Company, in each case consistent with the requirements with respect to all directors of
the Company. 
 Section 3 Committee Membership. After the Effective Date, and subject to applicable
law, the Company will offer at least one Investor Designee an opportunity to sit on each committee of the Board. If an Investor Designee fails to satisfy the applicable qualifications under law or stock exchange rule to sit on any committee of the
Board, then the Board shall offer such Investor Designee the opportunity to attend (but not vote at) the meetings of such committee as an observer. 

  
 5 

 Section 4 Compensation and Benefits. Each of the
Investor Designees will be entitled to receive similar compensation, benefits, reimbursement (including of travel expenses), indemnification and insurance coverage for their service as directors (or as board observers) as the outside directors of
the Company receive in connection with such service, except that the Investor Board Observers will not be entitled to compensation in connection with their service in such capacity. For so long as the Company maintains directors and officers
liability insurance, the Company shall include each Investor Designee as an “insured” for all purposes under such insurance policy for so long as such Investor Designee is a director of the Company and for the same period as for other
former directors of the Company when such Investor Designee ceases to be a director of the Company. The Company acknowledges and agrees that the rights of the Investor Designees under this Section 4 may be exercised prior
to exercising any indemnification, reimbursement, insurance or other rights such person may have with under arrangements made with the Investor or any of its affiliates. 

Section 5 Corporate Opportunities. 

(a) The Investor, SCP, and their respective Representatives (including the Investor Designees) (collectively, the “Investor
Parties”) may engage in the same or similar activities or related lines of business as those in which the Company or its Subsidiaries, directly or indirectly, may engage or other business activities that overlap with or compete with those
in which the Company or its Subsidiaries, directly or indirectly, may engage and the Company and its Subsidiaries may engage in material business transactions with any Investor Party from which the Company and its Subsidiaries are expected to
benefit. 
 (b) The Investor Parties shall not have any duty to refrain from engaging, directly or indirectly, in the same or similar
business activities or lines of business as the Company or its Subsidiaries. In the event that any Investor Party acquires knowledge of a potential transaction or matter that may be a corporate opportunity for itself and the Company or any of its
Subsidiaries, neither the Company nor any of its Subsidiaries shall have any expectancy in such corporate opportunity, and the Investor Party shall not have any duty to communicate or offer such corporate opportunity to the Company or any of its
Subsidiaries and may pursue or acquire such corporate opportunity for itself or direct such corporate opportunity to another Person, including one of its affiliates. 

(c) Without limiting the generality of the foregoing, the Company and the Board hereby renounce any interest or expectancy of the Company or
any of its Subsidiaries in, or in being offered an opportunity to participate in, any business opportunity, and waive any other “corporate opportunity” or similar restriction, in each case in favor of the Investor Parties to the fullest
extent permitted by law, including pursuant to Section 122(17) of the Delaware General Corporation Law. 

Section 6 Special Approval Matters. For so long as the Investor has the right to nominate an Investor
Designee to the Board pursuant to Section 2(a), the following actions by the Company or any Subsidiary of the Company (directly or indirectly) will require the approval of the Investor to proceed with such matter: 

  
 6 

 (a) the amendment or modification of the Company’s Certificate of Incorporation
(including the Certificate of Designations) or Bylaws in any manner that materially and adversely affects the Investor or any of its affiliates; 

(b) the incurrence, assumption, guarantee, of or becoming liable for any Indebtedness, except: (i) Indebtedness incurred pursuant to the
Refinancing (as defined in the Investment Agreement) and (ii) Indebtedness in the aggregate principal amount equal to the product of (A) 10% and (B) the aggregate principal amount of the Indebtedness incurred pursuant to clause (i) (other
than any Indebtedness incurred to refinance, roll-over, replace or renew any Indebtedness existing on the date of this Agreement, so long as, in each case, (x) the principal amount of such refinancing, roll-over, replacement or renewed
Indebtedness is not greater than the principal amount of the Indebtedness being refinanced, rolled-over, replaced or renewed (plus accrued interest, and a reasonable amount of premium, fees and expenses incurred in connection with such refinancing)
and (y) such Indebtedness is on customary commercial terms consistent in all material respects with the Indebtedness being refinanced, rolled-over, replaced or renewed without additional interest or penalty);  

(c) (i) the creation, issuance, sale, grant or authorization of the issuance, sale or grant of any equity securities of the Company or
any of its Subsidiaries (or any securities convertible into, exercisable or exchangeable for such equity securities) or (ii) the amendment of any term of any securities of the Company or any of the its Subsidiaries (or any securities
convertible into or exchangeable for such equity securities), in each case, whether by merger, consolidation or otherwise, and which would, individually or in the aggregate, exceed 10% of the outstanding Common Stock; 

(d) any increase in the size of the Board that results in there being more than eight directorships aside from Investor Designees; and 

(e) the acquisition of any assets or properties (in one or more related transactions) for cash or otherwise for an amount in excess of
$75 million in the aggregate (other than acquisitions of inventory and equipment in the ordinary course of business). 

Section 7 Restrictions on Transfer. 

(a) (i) Until the fourth anniversary of the Effective Date, the Investor shall not, directly or indirectly, sell, transfer or otherwise
dispose of (“Transfer”) any Series A Preferred Stock or the Note without the Company’s prior written consent; and (ii) (x) until the third anniversary of the Effective Date (the “Common Stock Transfer
Period”), the Investor shall not, directly or indirectly, Transfer any Common Stock or the Contingent Payment Right without the Company’s prior written consent and (y) following the third anniversary of the Effective Date, the
Investor shall not sell any Common Stock into the public market unless the amount of shares of Common Stock sold meets at least one of the following tests: (A) such amount, in any one (1) day, do not exceed twenty percent (20%) of the
average daily trading volume of the Common Stock during the four calendar weeks preceding such day or (B) such amount, together with the amount of any other such sales of Common Stock by the Investor within the preceding three months, does not
exceed two-and-one-half percent (2.5%) of the shares of Common Stock outstanding as shown by the most recent Annual Report on
Form 10-K or Current Report on Form 10-Q filed by the Company with the SEC preceding such sale, provided that this subclause (y) shall not apply to any transaction
that is exempt from the registration requirements of the Securities Act or any underwritten offering (for the avoidance of doubt, including block trades). 

  
 7 

 (b) Notwithstanding the foregoing Section 7(a), the following
Transfers (“Permitted Transfers”) shall be permitted directly or indirectly without the Company’s consent: 
 (i) to a
Permitted Holder who agrees to be bound by the terms of this Agreement; 
 (ii) in connection with a Cashless Conversion (as defined in the
Contingent Payment Right Agreement); 
 (iii) in connection with a redemption pursuant to the terms of the Certificate of Designations; 

(iv) in connection with any swap or any other agreement, transaction or series of transactions that hedges or transfers, in whole or in part,
directly or indirectly, the economic consequence of ownership of such Securities, whether any such transaction, swap or series of transactions is to be settled by delivery of securities, in cash or otherwise; 

(v) to any third-party pledgee in a bona fide transaction as collateral to secure obligations pursuant to lending or other arrangements
between such third parties (or their affiliates or designees) and the Investor and/or its affiliates or any similar arrangement relating to a financing arrangement for the benefit of the Investor and/or its affiliates, including pursuant to any
foreclosure or other exercise of remedies in connection therewith; 
 (vi) in any merger, consolidation, tender or exchange offer or other
business combination; 
 (vii) in any Pro Rata Transaction; and 

(viii) (x) with respect to any Transfer of the Note, so long as an Event of Default (as defined in the Note) has occurred and is
continuing; and (y) with respect to any Transfer of the Preferred Stock, so long as any breach any of the provisions set forth in Section 6 of the Certificate of Designations or any Specified Breach (as defined in the Certificate of
Designations) has occurred and is continuing. 
 (c) For purpose of this Agreement, a “Pro Rata Transaction” shall mean any
transaction in which (i) all holders of Common Stock (x) are offered terms substantially similar to those given to the Investor (as described in clause (y) below), or otherwise are offered the opportunity to, or will, participate in
such transaction on a pro rata basis, and (y) are entitled to receive consideration of equal market value (on a per share or as-converted basis) and (ii) the Series A Preferred Stock is treated in
such transaction in accordance with its terms. The Company shall cooperate with, and not frustrate, any Transfers by the Investor or Permitted Holders that are not prohibited by this Agreement. 

  
 8 

 Section 8 Standstill Restrictions. Provided that the
Company is not in material breach of this Agreement (which breach, if curable, has not been cured within thirty (30) days following the date of notice of such breach, it being understood that a breach of Section 2 shall be deemed material
and uncurable), until the earlier of (x) the time that the Investor’s beneficial ownership of the Common Stock (calculated on an As-Converted Basis) is less than 5% and (y) the third anniversary
of the Effective Date, the Investor and its affiliates acting at its direction shall not (i) directly or indirectly acquire, or agree to acquire, any equity securities of the Company, other than the Securities or as otherwise would not increase
the Investor’s beneficial ownership of the Common Stock (calculated on an As-Converted Basis) to greater than 40.00% (it being understood that nothing in this Section 8 shall restrict the Investor
from exercising its rights under Section 9 hereof), (ii) deposit any shares of Common Stock in a voting trust or similar arrangement or subject any shares of Common Stock to any voting agreement, pooling arrangement or
similar arrangement, or grant any proxy with respect to any shares of Common Stock to any person not affiliated with the Investor or Company management; (iii) make, or in any way participate or engage in, directly or indirectly, any
solicitation of proxies to vote, or seek to advise or influence any person with respect to the voting of, any voting securities of the Company or any Subsidiary of the Company, (iv) form, join or in any way participate in a “group”
(within the meaning of Section 13(d)(3) of the Exchange Act) with respect to any voting securities of the Company except for any group constituting solely of the Investor and Permitted Holders or a group with beneficial ownership under the
maximum threshold set forth in subclause (i) above, (v) seek the removal of any directors from the Board other than Investor Designees, (vi) call, or request the calling of, a special meeting of the stockholders of the Company or
(vii) make, or take, any action that would reasonably be expected to cause the Company to make a public announcement regarding any intention of the Investor to take an action that would be prohibited by the foregoing; provided, that
nothing in this Agreement shall restrict (1) the consummation of the Transactions (as defined in the Investment Agreement), (2) the Investor or any of its Representatives from making private proposals to the Board, (3) the Investor or any
of its Representatives from complying with applicable law, including making any disclosure that may become required by applicable law or (4) the ability of the Investor Designees from exercising their fiduciary duties or powers as directors.

 Section 9 Preemptive Rights. 

(a) For so long as the Investor’s As-Converted Common Stock Ownership Percentage is at least 10%,
the Investor will have the preemptive rights set forth in this Section 9 with respect to any issuance of any Common Stock or Equity-Linked Securities that are issued after the Effective Date (any such issuance, other than
those described in clauses (x) through (z) below, a “Preemptive Rights Issuance”), except for (1) issuances solely to employees, officers, consultants, agents and directors pursuant to and in accordance with the
Company LTIP in the form publicly filed with the SEC prior to the Effective Date (provided that any such issuances are made in accordance with the terms, conditions and limitations of the Company LTIP as they existed as of the date of hereof
and without giving effect to any amendments or other modifications thereof after the Effective Date unless approved in writing by the Investor) or pursuant to stock incentive plans or similar plans or programs of the Company that are approved by the
Board and publicly filed with the SEC after the Effective Date, (2) sales of Common Stock pursuant to a registered and broadly distributed underwritten public offering if such transaction was approved in accordance with the Company Charter
Documents (including the Certificate of Designations and the terms of 

  
 9 

 
this Agreement), (3) issuances of any securities issued as a result of a stock split, stock dividend, reclassification or similar event affecting all of the outstanding Common Stock, (4) the
issuance of the Series A Preferred Stock in connection with conversion of the Note or the issuance of Common Stock in connection with the conversion of the Contingent Payment Right, or (5) shares of a Subsidiary of the Company issued to the
Company or a wholly owned Subsidiary of the Company. 
 (b) If the Company at any time or from time to time effects a Preemptive Rights
Issuance, the Company shall give prompt written notice to the Investor (but in no event later than ten (10) days prior to such issuance), which notice shall set forth the number and type of the securities to be issued, the issuance date, the
offerees or transferees, the price per security, and all of the other terms and conditions of such issuance, which shall be deemed updated by delivery of the final documentation for such issuance to the Investor. The Investor may, by written notice
to the Company (a “Preemptive Rights Notice”) delivered at any time thereafter but no later than thirty (30) days after the consummation of such Preemptive Rights Issuance, elect to purchase (or designate an affiliate to
purchase) a number of securities specified in such Preemptive Rights Notice (which number may be any number up to but not exceeding the Preemptive Rights Cap Amount applicable to such Preemptive Rights Issuance), on the same terms and conditions as
such Preemptive Rights Issuance (it being understood and agreed that (i) the price per security that the Investors shall pay shall be the same as the price per security set forth in the Preemptive Rights Notice, and (ii) the Investors
shall not be required to comply with any terms, conditions, obligations or restrictions (including, without limitation, any non-compete, standstill or other limitations but excluding any remaining period of a
transfer or lock-up restriction applicable at such time to other purchasers in such Preemptive Rights Issuance) not necessary for the effectuation of the sale or issuance of such securities). If the Investor
exercises its preemptive rights hereunder with respect to such Preemptive Rights Issuance, the Company shall (or shall cause such subsidiary to) issue to the Investor (or its designated affiliate) the number of securities specified in such
Preemptive Rights Notice promptly thereafter (and provided that, if the Investor shall have so notified the Company at least three (3) business days prior to the issuance date set forth in the Company’s notice, at the Investor’s
election such purchase and sale shall occur on the same date as, and immediately following, the Preemptive Right Issuance). For the avoidance of doubt, in the event that the issuance of Common Stock or Equity-Linked Securities in a Preemptive Rights
Issuance involves the purchase of a package of securities that includes Common Stock or Equity-Linked Securities and other securities in the same Preemptive Rights Issuance, the Investor shall have the right to acquire its pro rata portion of such
other securities, together with its pro rata portion of such Common Stock or Equity-Linked Securities, in the same manner described above (as to amount, price and other terms), or solely acquire the Common Stock or Equity-Linked Securities. 

(c) The election by the Investor not to exercise its preemptive rights hereunder in any one instance shall not affect its right as to any
future Preemptive Rights Issuances. 
 Section 10 Books and Records; Access. The Company shall
permit the Investor and its designated representatives, at reasonable times and upon reasonable prior notice to the Company, to examine, and make copies of and abstracts from, the records and books of account of the Company and its Subsidiaries and
to discuss the affairs, finances and condition of the Company or any of its Subsidiaries with the officers of the Company or any such Subsidiary and 

  
 10 

 
the Company’s independent accountants. In addition, for so long as the Investor has the right to nominate an Investor Designee to the Board pursuant to
Section 2(a), upon written request of the Investor, the Company shall provide to the Investor duplicate copies of such financial and other information concerning the Company and its Subsidiaries as may from time to time be
reasonably requested by such Investor. 
 Section 11 Section 16b-3. So long as the Investor has the right to nominate an Investor Designee to the Board pursuant to Section 2(a), the Board shall take such action as is reasonably
necessary to cause the exemption of any acquisition or disposition (or deemed acquisition or disposition) of shares of Common Stock, Series A Preferred Stock, the Note or Contingent Payment Right or any other securities by the Investor from the
liability provisions of Section 16(b) of the Exchange Act pursuant to Rule 16b-3 so long as such exemption is not prohibited by applicable law; for the avoidance of doubt, the Company shall pass one
or more exemptive resolutions by the Board each time there is any purported acquisition or disposition of shares of Common Stock, Series A Preferred Stock, the Note or Contingent Payment Right or any other capital stock of the Company by the
Investor with requisite specificity to exempt such purported acquisition or disposition from the liability provisions of Section 16(b) of the Exchange Act pursuant to Rule 16b-3. 

Section 12 Confidentiality. 

(a) The parties acknowledge and agree that each Investor Designee may share Confidential Information with Investor and its affiliates, to the
extent reasonably necessary to monitor, evaluate or otherwise make decisions in connection with its investment in the Securities or the Company. The Investor will keep confidential and will not disclose, divulge, or use for any purpose (other than
with respect to its investment in the Company) any Confidential Information obtained from the Company pursuant to this Section 12; provided, however, that the Investor may disclose confidential information
(i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with its investment in the Company; (ii) to any prospective purchaser of any Securities from the
Investor, if such prospective purchaser agrees in writing to be bound by the provisions of this Section 12; (iii) in connection with periodic reports to its investors, partners, affiliates or members, the Investor may
provide summary information regarding the Company’s financial information in such reports, as long as such investors, partners, affiliates and members are advised that such information is confidential; or (iv) as may otherwise be required
by Law, provided that the Investor promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure. 

(b) Notwithstanding anything to the contrary herein, the restrictions contained in Section 12 shall not apply to
information furnished to an Investor Designee in his or her capacity as a director of the Company to the extent of his or her lawful use of such information in such capacity. Nothing herein shall limit any such persons from fulfilling his or her
fiduciary duties as members of the Board. 
 (c) For so long as the Investor holds any Securities, and except for legally required
disclosures the Company, its Subsidiaries and their respective officers and directors shall not, and the Company will cause its and its Subsidiaries’ employees not to, without the prior approval of the Investor, use the corporate name, trade
name or logo of the Investor or any Permitted Holder, any of its affiliates, any of their investment funds or any portfolio companies of such investment funds in a public manner or format (including reference on or links to websites and press
releases). 

  
 11 

 Section 13 No Inconsistent Agreements; Additional
Rights. The Company represents and warrants that it has not entered into, and agrees that it will not enter into, any agreement with respect to its securities that violates or subordinates or is otherwise inconsistent with the rights granted
to the Investor under this Agreement. 
 Section 14 Governing Law. This Agreement shall be governed
by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the
laws of any jurisdiction other than the State of Delaware. 
 Section 15 Specific Enforcement;
Jurisdiction. 
 (a) The parties agree that irreparable damage would occur and the parties would not have any adequate remedy at law
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, except as provided in the following sentences. It is accordingly agreed that (i) the parties shall
be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement from the Chancery Court of the State of Delaware and any state appellate court therefrom
within the State of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware), without proof of damages, without bond or other
security being required, this being in addition to any other remedy to which they are entitled under this Agreement, at law or in equity, (ii) the provisions set forth in this Section 15 (A) are not intended to and do
not adequately compensate for the harm that would result from a breach of this Agreement and (B) shall not be construed to diminish or otherwise impair in any respect any party’s right to specific enforcement, and (iii) the right of
specific enforcement is an integral part of the Transactions and without that right neither the Company nor the Investor would have entered into this Agreement. 

(b) Each party hereto irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement brought by any other
party hereto or its successors or assigns shall be brought and determined in the Chancery Court of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, only if the Chancery Court declines to accept
jurisdiction over a particular matter, in any state or federal court within the State of Delaware), and each party hereby irrevocably submits to the exclusive jurisdiction of the aforesaid courts for itself and with respect to its property,
generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this Agreement and the Transactions. Each party agrees not to commence any action, suit or proceeding relating thereto except in the courts
described above in the State of Delaware, other than actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in the State of Delaware as described herein. Each party irrevocably consents to
the service of process outside the territorial jurisdiction of the courts referred to in this Section 15 in any such action or proceeding by mailing copies thereof by registered or certified United States mail, postage
prepaid, return receipt requested, to 

  
 12 

 
its address as specified in or pursuant to Section 19. However, the foregoing shall not limit the right of a party to effect service of process on the other party by any
other legally available method. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING BETWEEN THE PARTIES HERETO ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS. 

Section 16 Successors and Assigns. Except as otherwise provided in this Agreement, the provisions of
this Agreement shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors, and administrators of the parties. Neither this Agreement nor any of the rights or obligations under this Agreement shall be assigned, in
whole or in part, by any party without the prior written consent of the other party. 
 Section 17 No
Third-Party Beneficiaries. Notwithstanding anything contained in this Agreement to the contrary, nothing in this Agreement, expressed or implied, is intended to confer, and this Agreement shall not confer, on any Person other than the
parties to this Agreement any rights, remedies, obligations or liabilities under or by reason of this Agreement, and no other Persons shall have any standing with respect to this Agreement or the transactions contemplated by this Agreement. 

Section 18 Entire Agreement. This Agreement, the Investment Agreement, the Certificate of
Designations, the Contingent Payment Right Agreement, the Note, the Registration Rights Agreement and the other documents delivered pursuant to the Investment Agreement constitute the full and entire understanding and agreement among the parties
hereto with regard to the subjects of this Agreement and such other agreements and documents. This Agreement shall not be effective until the Effective Date. 

Section 19 Notices. Except as otherwise provided in this Agreement, all notices, requests, claims,
demands, waivers and other communications required or permitted under this Agreement shall be in writing and shall be mailed by reliable overnight delivery service or delivered by hand, facsimile or messenger, and email, as follows: 

 

			
	 if to the Company:
	  	 Consolidated Communications Holdings, Inc.
 350
S. Loop 336 W
 Conroe, Texas 77304
 Attention: J. Garrett Van
Osdell, Chief Legal Officer
 Email: Garrett.VanOsdell@consolidated.com

		
	 with a copy to:
	  	 Schiff Hardin LLP
 233 South Wacker Drive, Suite
7100
 Chicago, Illinois 60606
 Attention: Alex Young

Email: ayoung@schiffhardin.com

  
 13 

			
	 if to the Investor:
	  	 Searchlight III CVL, L.P.
 c/o Searchlight
Capital Partners, L.P.
 745 Fifth Avenue, 27th Floor
 New York,
New York 10151
 Attention: Nadir Nurmohamed
 Email:
nnurmohamed@searchlightcap.com

		
	 with a copy to:
	  	 Wachtell, Lipton, Rosen & Katz
 51 West
52nd Street
 New York, NY 10019

Facsimile: (212) 403-2000

Attention: Steven A. Cohen

                 Victor Goldfeld

Email: SACohen@wlrk.com

                 VGoldfeld@wlrk.com

 or in any such case to such other address, facsimile number, e-mail address, or
telephone as any party hereto may, from time to time, designate in a written notice given in a like manner. Notices shall be deemed given when actually delivered by overnight delivery service, hand or messenger, or when received by facsimile or e-mail if promptly confirmed. 
 Section 20 Delays or Omissions.
No delay or omission to exercise any right, power, or remedy accruing to any party under this Agreement shall impair any such right, power, or remedy of such party, nor shall it be construed to be a waiver of or acquiescence to any breach or
default, or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default. All remedies, either under this Agreement or by law or otherwise afforded to
the Investor, shall be cumulative and not alternative. 
 Section 21 Amendments and Waivers. Any
term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only if such amendment or waiver is in writing and signed,
in the case of an amendment, by the Company and the Investor or, in the case of a waiver, by the party against whom the waiver is to be effective. Any consent hereunder and any amendment or waiver of any term of this Agreement by the Company must be
approved by a majority of directors voting who are not Investor Designees. 
 Section 22
Counterparts. This Agreement may be executed in any number of counterparts and signatures may be delivered by facsimile or in electronic format, each of which may be executed by less than all the parties, each of which shall be
enforceable against the parties actually executing such counterparts and all of which together shall constitute one instrument. 

Section 23 Severability. If any provision of this Agreement becomes or is declared by a court of
competent jurisdiction to be illegal, unenforceable, or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement and the balance of this Agreement shall be enforceable in
accordance with its terms. 
 Section 24 Titles and Subtitles; Interpretation. The titles and
subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement. When a reference is made in this Agreement to a Section or Schedule, such

  
 14 

 
reference shall be to a Section or Schedule of this Agreement unless otherwise indicated. Whenever the words “include,” “includes” or “including” are used in this
Agreement, they shall be deemed to be followed by the words “without limitation.” The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the
feminine and neuter genders of such term. Any agreement, instrument or statute, rule or regulation defined or referred to in this Agreement means such agreement, instrument or statute, rule or regulation as from time to time amended, modified or
supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes. Any reference to any section under the Securities Act or Exchange Act, or any rule
promulgated thereunder, shall include any publicly available interpretive releases, policy statements, staff accounting bulletins, staff accounting manuals, staff legal bulletins, staff “no-action,”
interpretive and exemptive letters, and staff compliance and disclosure interpretations (including “telephone interpretations”) of such section or rule by the SEC. Each of the parties has participated in the drafting and negotiation of
this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if it is drafted by each of the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of authorship of any of the provisions of this Agreement. 
 [signature page follows] 

  
 15 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	CONSOLIDATED COMMUNICATIONS HOLDINGS, INC.
		
	By:	 	 /s/ C. Robert Udell

		 	Name: C. Robert Udell
		 	Title: President & CEO

  

			
	SEARCHLIGHT III CVL, L.P.
	
	 By: Searchlight III CVL GP, LLC

       its general partner

		
	By:	 	 /s/ Andrew Frey

		 	Name: Andrew Frey
		 	Title: Authorized Person

 [Signature Page to Governance Agreement] 

 EXHIBIT A 

Board 
 Investor Designees

 Initial Closing 
 Name: David Fuller 

FCC Approval 
 Name: Andrew Frey 

Investor Board Observers 
 Between the Initial
Closing and the receipt of the FCC Approval: Andrew Frey 
 Upon receipt of the FCC Approval: Ryan YaraghiEX-4.3

 Exhibit 4.3 

GOODRX HOLDINGS, INC. 

STOCKHOLDERS AGREEMENT 

Dated as of [●], 2020 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
		
	ARTICLE I DEFINITIONS	  	 	1	 
			
	 Section 1.1
	 	Definitions	  	 	1	 
	 Section 1.2
	 	General Interpretive Principles	  	 	6	 
		
	ARTICLE II MANAGEMENT	  	 	7	 
			
	 Section 2.1
	 	Board of Directors	  	 	7	 
	 Section 2.2
	 	Controlled Company	  	 	10	 
		
	ARTICLE III POST-IPO TRANSFERS	  	 	10	 
			
	 Section 3.1
	 	Notices	  	 	10	 
	 Section 3.2
	 	Registration Rights	  	 	11	 
	 Section 3.3
	 	Private Placements	  	 	11	 
	 Section 3.4
	 	Coordination of Rule 144 Sales	  	 	11	 
	 Section 3.5
	 	Partner Distributions	  	 	12	 
	 Section 3.6
	 	Other Restrictions on Transfer	  	 	13	 
	 Section 3.7
	 	Permitted Transfers	  	 	13	 
	 Section 3.8
	 	Idea Men Participation	  	 	14	 
	 Section 3.9
	 	Termination of Article III	  	 	14	 
		
	ARTICLE IV ADDITIONAL AGREEMENTS OF THE PARTIES	  	 	14	 
			
	 Section 4.1
	 	Exculpation Among Stockholders	  	 	14	 
	 Section 4.2
	 	Confidentiality	  	 	14	 
		
	ARTICLE V ADDITIONAL PARTIES	  	 	15	 
			
	 Section 5.1
	 	Additional Parties	  	 	15	 
		
	ARTICLE VI MISCELLANEOUS	  	 	15	 
			
	 Section 6.1
	 	Amendment	  	 	15	 
	 Section 6.2
	 	Corporate Opportunities	  	 	15	 
	 Section 6.3
	 	Termination	  	 	16	 
	 Section 6.4
	 	Non-Recourse	  	 	16	 
	 Section 6.5
	 	No Third Party Beneficiaries	  	 	16	 
	 Section 6.6
	 	Recapitalizations; Exchanges, Etc.	  	 	17	 
	 Section 6.7
	 	Addresses and Notices	  	 	17	 
	 Section 6.8
	 	Binding Effect	  	 	18	 
	 Section 6.9
	 	Waiver	  	 	18	 
	 Section 6.10
	 	Counterparts	  	 	18	 
	 Section 6.11
	 	Applicable Law; Waiver of Jury Trial	  	 	19	 

  
 i 

							
	 Section 6.12
	 	Severability	  	 	19	 
	 Section 6.13
	 	Delivery by Facsimile	  	 	19	 
	 Section 6.14
	 	Entire Agreement	  	 	19	 
	 Section 6.15
	 	Remedies	  	 	20	 
	 Section 6.16
	 	Settlement	  	 	20	 

 Exhibit A - Form of Joinder to Stockholders Agreement 

Exhibit B - Form of Director & Officer Indemnification Agreement 

  
 ii 

 STOCKHOLDERS AGREEMENT 

This STOCKHOLDERS AGREEMENT (as the same may be amended from time to time in accordance with its terms, the “Agreement”) is
entered into as of [ ● ], 2020, by and among (i) GoodRx Holdings, Inc., a Delaware corporation (the “Issuer”); (ii) the Silver Lake Stockholders (as hereinafter defined); (iii) the Francisco Partners
Stockholders (as hereinafter defined), (iv) the Spectrum Stockholders (as hereinafter defined), and (v) the Idea Men Stockholders (as hereinafter defined), and any other Person who becomes a party hereto pursuant to
Article VI (each a “Stockholder” and, collectively, the “Stockholders”). 

WHEREAS, in connection with the consummation by the Issuer of an IPO (as hereinafter defined), and pursuant to the terms of the Amended and
Restated Stockholders Agreement, dated as of October 12, 2018, by and among the parties hereto and certain other persons, the parties hereto have agreed to enter into this Agreement to govern certain of their rights, duties and obligations with
respect to their ownership of Shares (as hereinafter defined) after consummation of the IPO. 
 WHEREAS, pursuant to the Stock Purchase
Agreement, dated as of September [ ● ], 2020, by and among the Issuer and SLP Geology Aggregator, L.P., the Issuer has agreed to issue and sell shares of its Class A Common Stock (as defined herein) at a price per share equal to
the price per share in the IPO (as hereinafter defined), before underwriting discounts and expenses. 
 NOW, THEREFORE, in consideration of
the mutual covenants and agreements contained herein, the parties mutually agree as follows: 
 ARTICLE I 

DEFINITIONS 

Section 1.1    Definitions. As used in this Agreement, the following terms shall have the meanings set forth
below: 
 “Affiliate” means, with respect to any Person, any other Person that controls, is controlled by, or is under
common control with such Person. The term “control,” as used with respect to any Person, means the power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through the ownership
of voting securities, by contract or otherwise. “Controlled” and “controlling” have meanings correlative to the foregoing. Notwithstanding the foregoing, for purposes hereof, none of the Stockholders, the Issuer, or
any of their respective Subsidiaries shall be considered Affiliates of any portfolio operating company in which the Stockholders or any of their investment fund Affiliates have made a debt or equity investment, and none of the Stockholders or any of
their Affiliates shall be considered an Affiliate of (a) Issuer or any of its Subsidiaries or (b) each other. 

“Agreement” has the meaning set forth in the Preamble. 

“Amended and Restated Certificate of Incorporation” means the Issuer’s amended and restated certificate of incorporation
to be filed and effective in connection with the consummation of the IPO. 

  
 1 

 “Beneficial Ownership” and “Beneficially Own” and similar
terms have the meaning set forth in Rule 13d-3 under the Exchange Act; provided, however, that no Stockholder shall be deemed to beneficially own any securities of the Issuer held by any other
Stockholder solely by virtue of the provisions of this Agreement (other than this definition which shall be deemed to be read for this purpose without the proviso hereto). 

“Board” means the Board of Directors of the Issuer. 

“Business Day” means any day, other than a Saturday, Sunday or one on which banks are authorized by law to be closed in New
York, New York. 
 “Catch-Up Shares” has the meaning set forth in
Section 3.8. 
 “Change in Control” means the occurrence of any of the following events: 

(a)    the sale or disposition, in one or a series of related transactions, of all or substantially all, of the assets of
the Issuer to any “person” or “group” (as such terms are defined in Section 13(d)(3) or 14(d)(2) of the Exchange Act), other than to the Stockholder Group or to any of the Stockholders, Trevor Bezdek, Douglas Hirsch or any
of their respective Affiliates (collectively, the “Permitted Holders”); 
 (b)    any person or group,
other than one or more of the Permitted Holders, is or becomes the Beneficial Owner, directly or indirectly, of more than 50% of the total voting power of the voting stock or interests, as applicable, of the Issuer (or any entity which controls the
Issuer or which is a successor to all or substantially all of the assets of the Issuer), including by way of merger, recapitalization, reorganization, redemption, issuance of capital stock, consolidation, tender or exchange offer or otherwise; or

 (c)    a merger of the Issuer with or into another Person (other than one of more of the Permitted Holders) in which
the voting stockholders or members, as applicable, of the Issuer immediately prior to such merger cease to hold at least 50% of the voting shares of the Issuer (or the surviving corporation or ultimate parent) immediately following such merger; 

provided that, in each case under clause (a), (b) or (c), no Change in Control shall be deemed to occur unless the Permitted Holders as a result
of such transaction cease to have the ability, without the approval of any Person who is not a Permitted Holder, to elect a majority of the members of the Board of Directors or other governing body of the Issuer (or the resulting entity), and in no
event shall a Change in Control be deemed to include any transaction effected for the purpose of (i) changing, directly or indirectly, the form of organization or the organizational structure of the Issuer or any of its Subsidiaries, or
(ii) contributing assets or equity to entities controlled by the Issuer (or owned by the Issuer in substantially the same proportions as their ownership of the Issuer). 

“Class A Common Stock” means the Class A common stock, par value $0.0001 per share, of the Issuer.

  
 2 

 “Class B Common Stock” means the Class B common
stock, par value $0.0001 per share, of the Issuer (including any shares of Class A common stock into which such Class B common stock converts). 

“Closing Date” means the date of the closing of the IPO. 

“Closing Price” has the meaning set forth in Section 3.5. 

“Combined Voting Power” means the combined voting power of all classes and series of Voting Securities, according to each
class’ or series’ respective votes per share, voting together as a single class. 
 “Common Stock” means,
collectively, the shares of Class A Common Stock and Class B Common Stock, and any securities issued in respect thereof, or in substitution therefor, in connection with any stock split, dividend or combination, or any reclassification,
recapitalization, merger, consolidation or similar transaction. 
 “Director” means any member of the Board from time to
time. 
 “Director Designee” means a Silver Lake Designee, a Francisco Partners Designee, the Spectrum Designee or an Idea
Men Designee. 
 “Distribution” has the meaning set forth in Section 3.5. 

“Distribution Cap” has the meaning set forth in Section 3.5. 

“Election Period” has the meaning set forth in Section 3.3. 

“Equity Securities” means any and all Shares, and any and all securities of the Issuer convertible into, or exchangeable or
exercisable for (whether or not subject to contingencies or the passage of time, or both), such shares, and options, warrants or other rights to acquire Shares. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder,
as the same may be amended from time to time. 
 “Francisco Partners Designee” has the meaning set forth in
Section 2.1(a)(ii). 
 “Francisco Partners Stockholders” means Francisco Partners IV, L.P. and
Francisco Partners IV-A, L.P. and any of their respective Permitted Transferees who hold Shares as of the applicable time. 

“Idea Men Designee” has the meaning set forth in Section 2.1(a)(iv). 

“Idea Men Stockholders” means Idea Men, LLC and any of its Permitted Transferees who hold Shares as of the applicable time.

 “Independent Director” means a Director who qualifies, as of the date of such Director’s election or appointment to
the Board (or any committee thereof) and as of any other date on which the determination is being made, as an “independent director” under the applicable rules of the 

  
 3 

 
Stock Exchange, as determined by the Board and as an “Independent Director” under Rule 10A-3 under the Exchange Act and any corresponding
requirement of Stock Exchange rules for audit committee members, as well as any other independence requirements of the U.S. securities laws that is then applicable to the Issuer, as determined by the Board. 

“Initial Public Offering” or “IPO” means the first underwritten Public Offering of the Class A Common
Stock of the Issuer. 
 “IPO Price” has the meaning set forth in Section 3.5. 

“Investor Rights Agreement” means the amended and restated investor rights agreement, dated as of October 12, 2018, by
and among the Issuer, SLP Geology Aggregator, L.P., Francisco Partners IV, L.P., Francisco Partners IV-A, L.P., Spectrum Equity VII, L.P., Spectrum VII Investment Managers’ Fund, L.P., Spectrum VII Co-Investment Fund, L.P. and Idea Men, LLC (as amended, restated, supplemented or otherwise modified from time to time). 

“Issuer” has the meaning set forth in the Recitals. 

“Issuer Competitor” means any Person that directly competes with the business of the Issuer and its direct and indirect
Subsidiaries as of the time of determination. 
 “Joinder Agreement” has the meaning set forth in
Section 5.1. 
 “Law,” with respect to any Person, means (a) all provisions of all laws,
statutes, ordinances, rules, regulations, permits, certificates or orders of any governmental authority applicable to such Person or any of its assets or property or to which such Person or any of its assets or property is subject and (b) all
judgments, injunctions, orders and decrees of all courts and arbitrators in proceedings or actions in which such Person is a party or by which it or any of its assets or properties is or may be bound or subject. 

“Notice” has the meaning set forth in Section 3.1. 

“Notice Period” has the meaning set forth in Section 3.4. 

“Permitted Holders” has the meaning set forth in the definition of “Change in Control”. 

“Permitted Transferee” means with respect to any Stockholder, any Person that such Stockholder is permitted to transfer
shares of Class B Common Stock to in accordance with the provisions of the Amended and Restated Certificate of Incorporation of the Issuer without such shares automatically converting to Class A Common Stock upon the occurrence of such
transfer. 
 “Person” means an individual, partnership, corporation, business trust, joint stock company, trust,
unincorporated association, joint venture, limited liability company or any other entity of whatever nature, and shall include any successor (by merger or otherwise) of such entity. 

“Private Placement” mean the issue and sale of Class A Common Stock to SLP Geology Aggregator, L.P. pursuant to that
certain Stock Purchase Agreement, dated as of September [ ● ], 2020, by and among GoodRx Holdings, Inc. and SLP Geology Aggregator, L.P. 

  
 4 

 “Public Offering” means any offering and sale of equity securities of the
Issuer or any successor to the Issuer for cash pursuant to an effective registration statement (other than on Form S-4, S-8 or a comparable form) under the Securities
Act. 
 “Rule 144” means Rule 144 under the Securities Act (or any successor rule or regulation). 

“Rule 144 Pro Rata Portion” means, as of any time of determination, with respect to any Stockholder, the maximum aggregate
number of shares of Class B Common Stock held by the Stockholders that are then permitted to be sold by the Stockholders as a group in accordance with Rule 144(e) (assuming for this purpose that each Stockholder is an affiliate and acting in
concert for purposes of Rule 144), multiplied by such Stockholder’s percentage ownership of the total number of issued and outstanding shares of Class B Common Stock held by all Stockholders immediately prior to such time of determination.
For the avoidance of doubt, the Rule 144 Pro Rata Portion shall not include any Shares purchased by a Stockholder in the Private Placement, IPO or on the open market following the IPO. 

“Rule 144 Transfer” has the meaning set forth in Section 3.4. 

“SEC” means the United States Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, as the
same may be amended from time to time. 
 “Shares” means shares of Common Stock. 

“Silver Lake Designee” has the meaning set forth in Section 2.1(a)(i). 

“Silver Lake Stockholders” means SLP Geology Aggregator, L.P. and any of its Permitted Transferees who hold Shares as of the
applicable time. 
 “Spectrum Designee” has the meaning set forth in Section 2.1(a)(iii). 

“Spectrum Stockholders” means Spectrum Equity VII, L.P., Spectrum VII Investment Managers’ Fund, L.P. and Spectrum VII Co-Investment Fund, L.P., and any of their Permitted Transferees who hold Shares as of the applicable time. 

“Stock Exchange” means The NASDAQ Global Select Market or such other securities exchange or interdealer quotation system on
which shares of Class A Common Stock are then listed or quoted. 
 “Stockholder” has the meaning set forth in the
Preamble. 
 “Stockholder Group” means the “group” (as such term is used in Section 13(d) of the Exchange
Act) consisting of SLP Geology Aggregator, L.P., Francisco Partners IV, L.P., Francisco Partners IV-A, L.P., Spectrum Equity VII, L.P., Spectrum VII Investment Managers’ Fund, L.P., Spectrum VII Co-Investment Fund, L.P. and Idea Men, LLC, in each case together with their Affiliates; provided, however, that none of Trevor Bezdek, Douglas Hirsch, The Bezdek Family Irrevocable Trust and The
Hirsch Family Irrevocable Trust shall be deemed to be Affiliates of Idea Men, LLC or otherwise included in the Stockholder Group. 

  
 5 

 “Subsidiary” means, with respect to any party, any corporation,
partnership, trust, limited liability company or other form of legal entity in which such party (or another Subsidiary of such party) holds stock or other ownership interests representing (a) more that 50% of the voting power of all outstanding
stock or ownership interests of such entity, (b) the right to receive more than 50% of the net assets of such entity available for distribution to the holders of outstanding stock or ownership interests upon a liquidation or dissolution of such
entity or (c) a general or managing partnership interest in such entity. 
 “Transfer” means, with respect to any
Shares, a direct or indirect transfer (including through one or more transfers), sale, exchange, assignment, pledge, hypothecation or other encumbrance or other disposition of such Shares, including the grant of an option or other right, whether
directly or indirectly, whether voluntarily, involuntarily or by operation of Law; provided that, for the avoidance of doubt, a transfer of an interest in an investment fund which is, or indirectly has an interest in, a Francisco Partners
Stockholder, a Silver Lake Stockholder or a Spectrum Stockholder and which is not intended to circumvent the provisions of this Agreement shall not constitute a “Transfer.” 

“Transferred”, “Transferring” and “Transferee” shall each have a correlative meaning to the
term “Transfer.” 
 “Transfer Restriction Period” means the period commencing on the Closing Date and
terminating on the third anniversary of the Closing Date. 
 “Voting Securities” means, at any time, outstanding shares of
any class of Equity Securities of the Issuer, which are then entitled to vote generally in the election of directors. 

Section 1.2    General Interpretive Principles. The name assigned to this Agreement and the
section captions used herein are for convenience of reference only and shall not be construed to affect the meaning, construction or effect hereof. Whenever required by the context, any pronoun used in this Agreement shall include the
corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa. Reference to any agreement, document or instrument means such agreement, document or instrument as amended
or otherwise modified from time to time in accordance with the terms thereof, and if applicable hereof. Unless otherwise specified, the terms “hereof,” “herein” and similar terms refer to this Agreement as a whole,
and references herein to Articles or Sections refer to Articles or Sections of this Agreement. For purposes of this Agreement, the words, “include,” “includes” and “including,” when used
herein, shall be deemed in each case to be followed by the words “without limitation.” The terms “dollars” and “$” shall mean United States dollars. The parties hereto have participated jointly in
the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall
arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. Wherever a conflict exists between this Agreement and any other agreement, this Agreement shall control but solely to the extent of such
conflict. 

  
 6 

 ARTICLE II 

MANAGEMENT 

Section 2.1    Board of Directors. 

(a)     Composition; Company Recommendation. Following the Closing Date, each Stockholder shall have the right, but
not the obligation, to designate for election to the Board, and the Issuer shall include such designees as nominees for election to the Board at all of the Issuer’s applicable annual or special meetings of stockholders (or consents in lieu of a
meeting) at which Directors are to be elected (adjusted as appropriate to take into account the Issuer’s classified Board structure), subject to satisfaction of all qualification and legal requirements regarding service as a Director in
accordance with Section 2.1(d), the number of designees that, if elected, will result in such Stockholder having the number of Directors serving on the Board as follows: 

(i)    So long as the Silver Lake Stockholders continue to collectively Beneficially Own (A) at least
20% of the Shares outstanding immediately following the Closing Date, the Issuer shall include in its slate of nominees three (3) Directors designated by the Silver Lake Stockholders, (B) less than 20% but at least 10% of the Shares
outstanding immediately following the Closing Date, two (2) Directors designated by the Silver Lake Stockholders, and (C) less than 10% but at least 5% of the Shares outstanding immediately following the Closing Date, one (1) Director
designated by the Silver Lake Stockholders (any such designee, a “Silver Lake Designee”). For so long as the Silver Lake Stockholders are entitled to designate three (3) Directors, one (1) Silver Lake Designee shall be an
Independent Director, provided that, if the Silver Lake Stockholders are entitled to designate less than three (3) Directors, no Silver Lake Designee need be an Independent Director. 

(ii)    So long as the Francisco Partners Stockholders continue to collectively Beneficially Own
(A) at least 10% of the Shares outstanding immediately following the Closing Date, the Issuer shall include in its slate of nominees two (2) Directors designated by the Francisco Partners Stockholders, and (B) less than 10% but at
least 5% of the Shares outstanding immediately following the Closing Date, one (1) Director designated by the Francisco Partners Stockholders (any such designee, a “Francisco Partner Designee”). 

(iii)    So long as the Spectrum Stockholders continue to collectively Beneficially Own at least 5% of the
shares of Common Stock outstanding immediately following the Closing Date, the Issuer shall include in its slate of nominees one (1) Director designated by the Spectrum Stockholders (any such designee, a “Spectrum Designee”).

 (iv)    Subject to Section 2.1(f), so long as the Idea Men Stockholders continue to collectively
Beneficially Own at least 5% of the Shares outstanding immediately following the Closing Date, the Issuer shall include in its slate of nominees two (2) Directors designated by the Idea Men Stockholders (any such designee, an “Idea Men
Designee”); provided that the Idea Men Designees shall be Trevor Bezdek for so long as he serves in his capacity as Chief Executive Officer or Co-Chief Executive Officer of the Issuer and/or
Douglas Hirsch for so long as he serves in his capacity as Chief Executive Officer or Co-Chief Executive Officer of the Issuer. For the avoidance of doubt, for so long as the Idea

  
 7 

 
Men Stockholders are entitled to designate two (2) Directors and Trevor Bezdek and Douglas Hirsch each serve as Co-Chief Executive Officer of the
Issuer, only Trevor Bezdek and Douglas Hirsch shall serve as the Idea Men Designees. To the extent Trevor Bezdek and Douglas Hirsch serve as Co-Chief Executive Officers or either of them serves as Chief
Executive Officer and the Idea Men Stockholders no longer have the right pursuant to this Section 2.1(a)(iv) to nominate Idea Men Designees, the Issuer shall continue to include in its slate of director nominees Trevor Bezdek and/or
Douglas Hirsch, as applicable, and each of the Silver Lake Stockholders, Francisco Partners Stockholders and Spectrum Stockholders shall take all actions necessary and within their control to nominate and elect such individuals. 

(b)    As of the Closing Date, the Board shall be comprised of ten (10) Directors as follows: 

(i)    The Directors initially designated for appointment to the Board (i) by the Silver Lake
Stockholders shall be Gregory Mondre, designated as a Class III Director, Adam Karol, designated as a Class II Director, and Agnes Rey Giraud, designated as a Class I Director, (ii) by the Francisco Partners Stockholders shall be
Dipanjan Deb, designated as a Class III Director and Christopher Adams, designated as a Class II Director, (iii) by the Spectrum Stockholders shall be Stephen LeSieur, designated as a Class III Director, and (iv) by the Idea
Men Stockholders shall be Trevor Bezdek, designated as a Class II Director, and Douglas Hirsch, designated as a Class I Director. 

(ii)    The Independent Directors initially designated for appointment to the Board are (i) Jacqueline
Kosecoff, designated as a Class I Director and (ii) Julie Bradley, designed as a Class III Director. For the avoidance of doubt, the initial Independent Director designee of Silver Lake Stockholders is Agnes Rey Giraud. 

(c)    The Issuer and each of the Stockholders shall take all actions necessary and within their control so that two
(2) Independent Directors who are not affiliated with any Stockholder and who are independent for Audit Committee purposes are nominated and elected to the Board; provided that, in the event that the Silver Lake Stockholders are no
longer required to nominate an Independent Director pursuant to Section 2.1(a), the number of Independent Directors to be nominated and elected to the Board pursuant to this Section 2.1(c) shall
increase to three (3) Independent Directors. 
 (d)    If the Issuer’s Nominating and Corporate Governance
Committee determines in good faith that a Director Designee (i) is not qualified to serve on the Board consistent with such committee’s duly adopted policies and procedures applicable to all directors or (ii) does not satisfy
applicable legal requirements regarding service as a Director, the applicable designating Stockholder shall have the right to designate a different Director Designee. Notwithstanding the foregoing, with respect to each Stockholder, at least one
member, partner or senior employee of such Stockholder shall be eligible to serve in such Stockholder’s Director Designee position. 

(e)    Except as provided in Section 2.1(a), if the number of individuals that any Stockholder
has the right to designate for election to the Board is decreased pursuant to Section 2.1(a), then the corresponding number of Director Designees of such Stockholder shall 

  
 8 

 
immediately offer to tender his or her resignation for consideration by the Board and, if such resignation is requested by the Board, such Director Designee or Director Designees shall resign
within thirty (30) days from the date that the Stockholder’s right to designate for election to the Board was decreased, subject to the proviso in the following sentence. In the event that the Board requests such resignation, the Issuer
and the Stockholders shall immediately take any and all actions necessary or appropriate to cooperate in ensuring the removal of such individual upon receipt of his or her resignation; provided that (i) the resignation of the last
remaining Director Designee designated by any Stockholder may, at his or her option, resign from the Board effective at the end of his or her then current term, and (ii) notwithstanding anything to the contrary herein, a Director Designee may
resign at any time regardless of the period of time left in his or her then current term. 
 (f)    Notwithstanding any
resolution adopted by the Board which determines the number of Directors constituting the whole Board, for so long as the Idea Men Stockholders continue to collectively Beneficially Own at least 5% of the Shares outstanding, in the event that the
number of individuals that the Silver Lake Stockholders, Francisco Partners Stockholders or Spectrum Stockholders have the right to designate for election to the Board is decreased pursuant to Section 2.1(a) for such
Stockholder, as applicable, number of Idea Men Designees shall automatically be increased by the corresponding number of Directors; provided that, for so long as any of the Silver Lake Stockholders and/or the Francisco Partners Stockholders
are entitled to designate at least one (1) Director at the time that the number of Silver Lake Designees, Francisco Partners Designees or Spectrum Designees is decreased pursuant to Section 2.1(a), the consent of each
such Silver Lake Stockholder and Francisco Partners Stockholder shall be required for any Idea Men Designee so designated to fill the vacancy caused by such decrease. 

(g)    Except as provided above and subject to the applicable provisions of the Amended and Restated Certificate of
Incorporation of the Issuer, each Stockholder shall have the sole and exclusive right to (i) direct the other Stockholders to vote all their Shares immediately for the removal of such Stockholder’s designees to the Board and
(ii) designate a Silver Lake Designee, Francisco Partners Designee, Spectrum Designee or Idea Men Designee, as applicable (serving in the same class as the predecessor), to fill vacancies on the Board pursuant to
Section 2.1(a) that are created by reason of death, removal or resignation of such Stockholder’s designees, subject to Section 2.1(d), (e) and (f). 

(h)    The Issuer and each of the Stockholders shall take all actions necessary and within their control to give effect to
the provisions contained in this Article II, including (i) in the case of the Issuer, soliciting proxies to vote for each Director Designee or Independent Directors designated by the Stockholders and otherwise using its best efforts to
cause each Director Designee and any Independent Directors designated by the Stockholders to be included as the only directors in the slate of nominees recommended by the Issuer and elected as a Director of the Issuer, and (ii) in the case of
the Stockholders, voting the Shares held directly or indirectly by such Stockholders (whether at a meeting or by consent) and any of their respective Affiliates, to cause the nomination, election, removal or replacement of the Director Designees or
Independent Directors designated by the Stockholders, in each case as provided for herein and otherwise using their best efforts to cause the Issuer to comply with its obligations hereunder. No Person shall take any action that would be inconsistent
with or otherwise circumvent the provisions of this Agreement; provided that each of the Stockholders may, in its sole discretion, elect not to designate any individual for election to the Board as such Stockholder’s respective Director
Designee. 

  
 9 

 (i)    The Issuer and its Subsidiaries shall reimburse the Directors for
all reasonable out-of-pocket expenses incurred in connection with their attendance at meetings of the Board or the board of directors of any of the Issuer’s
Subsidiaries, and any committees thereof, including without limitation travel, lodging and meal expenses, in accordance with the Issuer’s reimbursement policies. Except as otherwise determined by the Board, the Silver Lake Designees (other than
any Independent Director), Francisco Partners Designees, Spectrum Designees and Idea Men Designees shall not be compensated for their services as members of the Board. If the Issuer adopts a policy that Directors own a minimum amount of equity in
the Issuer, Director Designees shall not be subject to such policy. 
 (j)    The Issuer and its Subsidiaries shall
obtain customary director and officer indemnity insurance on commercially reasonable terms which insurance shall cover each member of the Board and the members of each board of directors of each of the Issuer’s Subsidiaries. The Issuer and its
Subsidiaries shall enter into director and officer indemnification agreements substantially in the form attached as Exhibit C hereto, with each of the Stockholders’ designees on the Board. 

Section 2.2    Controlled Company. 

(a)    The Stockholders acknowledge and agree that, (i) by virtue of this Article II, they are acting as a
“group” within the meaning of the Stock Exchange rules as of the date hereof, and (ii) by virtue of the Combined Voting Power of Common Stock held by the Stockholders, the Issuer shall qualify as a “controlled company”
within the meaning of Stock Exchange rules as of the Closing Date. 
 (b)    So long as the Issuer qualifies as a
“controlled company” for purposes of Stock Exchange rules, the Issuer may elect to be a “controlled company” for purposes of Stock Exchange rules, and will disclose in its annual meeting proxy statement that it is a
“controlled company” and the basis for that determination. If the Issuer ceases to qualify as a “controlled company” for purposes of Stock Exchange rules, the Stockholders and the Issuer will take whatever action may be
reasonably necessary in relation to such party, if any, to cause the Issuer to comply with Stock Exchange rules as then in effect within the timeframe for compliance available under such rules. 

ARTICLE III 
 POST-IPO TRANSFERS 
 Section 3.1    Notices. Notwithstanding any
terms applicable to, or obligations of, the Stockholders under the Investor Rights Agreement, each Stockholder agrees that until the expiration of the Transfer Restriction Period (or, if earlier, termination of this Article III in accordance with
Section 3.9 hereof) and subject to the exceptions in Section 3.7 hereof, it will, prior to (i) exercising any registration rights granted to such Stockholder pursuant to the Investor Rights
Agreement or (ii) otherwise making any Transfer of such Stockholder’s Shares (which, for the avoidance of doubt, shall include but not be limited to any underwritten public offering of Shares registered under the Securities Act, any
Transfer pursuant to an exemption from registration 

  
 10 

 
under the Securities Act, including pursuant to Rule 144, and any distribution), deliver a written notice (a “Notice”) to each other Stockholder setting forth the expected
material terms, conditions and details of the Transfer (including the method of Transfer, the number of Shares, the proposed trade date and, in the case of a Rule 144 sale, the volume limit applicable for the initial measurement period as of the
notice date), as applicable. 
 Section 3.2    Registration Rights. Following the delivery of a Notice
pursuant to Section 3.1 regarding the exercise of registration rights under the Investor Rights Agreement (which, for the avoidance of doubt, include demand registration, company registration and shelf takedown request
rights) the rights of the Stockholders to participate in any registered offering shall be governed by the terms of such Investor Rights Agreement; provided, that, notwithstanding anything to the contrary in the Investor Rights Agreement, each
Stockholder’s pro rata participation as calculated pursuant to the terms of the Investor Rights Agreement shall not include any Shares purchased by such Stockholder in the Private Placement, IPO or on the open market following the IPO. Any
Notice delivered pursuant to Section 3.1 regarding the exercise of registration rights under the Investor Rights Agreement shall be made prior to or concurrent with a notice to the Issuer under the Investor Rights
Agreement. 
 Section 3.3    Private Placements. Following the delivery of a Notice pursuant to
Section 3.1 regarding a Transfer of Shares other than a sale or distribution pursuant to Section 3.2 above or Section 3.4 or Section 3.5 below,
no Stockholder shall consummate such Transfer until seven (7) Business Days after the Notice has been delivered to the other Stockholders (the “Election Period”). Following receipt of such a Notice from a Stockholder, each
other Stockholder shall have the right to participate in the proposed Transfer by delivering written notice to the initiating Stockholder within three (3) Business Days. The failure by any Stockholder to deliver any such written notice to the
initiating Stockholder within such period shall be deemed to be an election by such Stockholder not to exercise its participation rights under this Section 3.3 with respect to such contemplated Transfer. Subject to the
exercise of such right to participate by any other Stockholder under this Section 3.3, the initiating Stockholder shall thereafter be free to sell the number of Shares identified in the Notice in the manner and on terms and
conditions no more favorable to the Stockholder than contemplated in the respective Notice. If a Stockholder elects to participate in such Transfer, such participating Stockholder shall be entitled to participate in such Transfer on a pro rata basis
based on such Stockholder’s proportionate ownership of all shares of Class B Common Stock held by all Stockholders participating in such Transfer. For the avoidance of doubt, the determination of each Stockholder’s pro rata
participation shall not include any Shares purchased by such Stockholder in the Private Placement, IPO or on the open market following the IPO. 

Section 3.4    Coordination of Rule 144 Sales. 

(a)    Following the delivery of a Notice pursuant to Section 3.1 regarding a sale pursuant to
Rule 144 (each, a “Rule 144 Transfer”), no Stockholder shall consummate such Rule 144 Transfer until three (3) Business Days after the Notice has been delivered to the other Stockholders (the “Notice Period”).
Each other Stockholder shall have the right to participate in a Rule 144 Transfer by delivering written notice to the initiating Stockholder within two (2) Business Days following receipt of such Notice. The failure by any Stockholder to
deliver any such written notice of participation within such period shall be deemed to be an election by such Stockholder not to 

  
 11 

 
exercise its participation rights under this Section 3.4 with respect to such contemplated Rule 144 Transfer. Subject to the exercise of such right to participate by any
other Stockholder under this Section 3.4, the initiating Stockholder shall thereafter be free to sell the number of Shares identified in the Notice in the manner and on the general terms and conditions contemplated in the
respective Notice during the initial Rule 144 measurement period (measured from the time of the original Notice) up to such Stockholder’s Rule 144 Pro Rata Portion; provided that if any Stockholder waives, in writing, its Rule 144 Pro
Rata Portion for the relevant measurement period, the other Stockholders may increase their respective number of Shares to be Transferred, on a pro rata basis, up to the amount of such non-participating
Stockholder’s Rule 144 Pro Rata Portion. All Stockholders electing to transfer Shares for value in a Rule 144 Transfer agree to use commercially reasonable efforts to coordinate the timing and process for transferring their Shares, including,
but not limited, selling through a single broker to be mutually agreed among such Stockholders. 
 (b)    Any
Stockholder may allocate Shares to a Rule 10b5-1 plan which authorizes a broker to sell the allocated Shares in one or more Rule 144 Transfers provided that the broker for such plan agrees that, prior to
effectuating any Rule 144 Transfers, the broker will provide the notice required by Section 3.4(a) and each of the other Stockholders will have the opportunity to sell its Rule 144 Pro Rata Portion in such Rule 144 Transfer. If an
initiating Stockholder provides notice under Section 3.4(a) that it intends to sell Shares in a Rule 144 Transfer, any other Stockholder may sell its Rule 144 Pro Rata Portion of Shares (including any
Catch-up Shares) pursuant to a Rule 10b5-1 plan; provided that, unless the broker for such plan has made the agreements specified in the preceding sentence that the
broker will provide the notice required by Section 3.4(a) prior to effectuating any Rule 144 Transfer, any Shares that remain unsold under such Rule 10b5-1 plan shall count
against such Stockholders Rule 144 Pro Rata Portion in a subsequent Rule 144 Transfer. 

Section 3.5    Partner Distributions. The Stockholders shall use commercially reasonable efforts to coordinate
any partner distributions or similar redemption of equity interests (any such distribution or redemption, a “Distribution”) in accordance with this Section 3.5. Prior to the first anniversary of the Closing
Date and provided that, as of the date of the distribution Notice, the last reported closing price of the Class A Common Stock on the exchange on which the Class A Common Stock is listed (the “Closing Price”) was at least
1.5 times the price per share set forth on the cover page of the final prospectus for the IPO (the “IPO Price”) (subject to adjustment for any stock split, reverse stock split, reclassification or otherwise), the Stockholders shall
be entitled to make one Distribution up to the Distribution Cap (as defined below). Subsequent to the first anniversary of the Closing Date, the Stockholders shall be entitled to make one Distribution up to the Distribution Cap (as defined below)
per quarter. Following the delivery of a Notice from a Stockholder pursuant to Section 3.1 regarding such a Distribution, no Stockholder shall consummate any such Distribution until ten (10) Business Days after the
Notice has been delivered to the other Stockholders. Each other Stockholder shall have the right to conduct a substantially concurrent Distribution by delivering written notice to the initiating Stockholder within five (5) Business Days of
receipt of such Notice. The failure by any Stockholder to deliver any such written notice within such period shall be deemed to be an election by such Stockholder not to exercise its participation rights under this
Section 3.5 with respect to such contemplated Transfer. Subject to the exercise of such right to participate by any other Stockholder under this Section 3.5, the initiating Stockholder shall
thereafter be free to distribute the Shares identified in the Transfer Notice in the manner and on the general terms and conditions contemplated in the respective 

  
 12 

 
Transfer Notice, including the proposed timing of such Distribution. Each Stockholder shall be entitled to Distribute no more than the greater of (i) such Stockholder’s Rule 144 Pro
Rata Portion or (ii) one percent (1%) of the Issuer’s market capitalization as of the date of delivery of the Notice described in this Section 3.5 (the “Distribution Cap”); provided that if
any Stockholder elects not to make any such Distribution (or effect a substantially contemporaneous sale under Section 3.2, 3.3 or 3.4, which for purposes of this proviso, shall be treated as Shares distributed in the Distribution), the other
Stockholders may increase their respective number of Shares to be distributed or redeemed in the Distribution, on a pro rata basis, up to the amount of such non-distributing Stockholder’s Distribution
Cap. Notwithstanding anything to the contrary, this Section 3.5 shall not govern with respect to Distributions of the sort described in Section 3.7(c) and shall not be deemed to apply to the Idea
Men Stockholders. 
 Section 3.6    Other Restrictions on Transfer. The restrictions on Transfer contained
in this Agreement are in addition to any other restrictions on Transfer to which a Stockholder may be subject, including any restrictions on Transfer contained in any equity incentive plan, restricted stock agreement, stock option agreement, stock
subscription agreement or other agreement to which such Stockholder is a party or instrument by which such Stockholder is bound. 

Section 3.7    Permitted Transfers. Notwithstanding anything to the contrary herein, the restrictions set
forth in this Article III, shall not apply to: 
 (a)    Transfers by a Stockholder to another corporation, partnership,
limited liability company or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of such transferring Stockholder, or to any investment fund or other entity controlled or
managed by such Stockholder or affiliates of such Stockholder, provided that any Distributions shall be subject to the provisions of Section 3.5 and Section 3.7(c), as applicable,
hereof. 
 (b)    Transfers pursuant to a bona fide third-party tender offer, merger, consolidation or other similar
transaction that is approved by the Board involving the Transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (as
defined in Section 13(d)(3) of the Exchange Act), of shares of capital stock if, after such Transfer, such person or group of affiliated persons would beneficially own (as defined in Rules 13d-3 and 13d-5 under the Exchange Act) at least a majority of the outstanding voting securities of the Issuer (or the surviving entity). 

(c)    Transfers in connection with distributions to certain current and/or former officers, employees or partners of the
general partner, managing member or other controlling entity of, or investment advisor to, a Stockholder and/or its affiliates which are made in conjunction with a Transfer pursuant to Section 3.2, 3.3 or 3.4,
provided that (i) unless otherwise consented to by the other Stockholders participating in the applicable Transfer, the aggregate number of such transferred shares of Common Stock by all such officers, employees and partners pursuant to
this clause (c) in conjunction with a particular Transfer shall not exceed 25% of the number of shares of Common Stock being Transferred by the applicable Stockholder and its Affiliates in such Transfer, and (ii) the aggregate number of
such transferred shares of Common Stock pursuant to this clause (c) shall be counted as Transferred by the distributing Stockholder in the accompanying Transfer pursuant to Section 3.2, 3.3 or 3.4 for
purposes of calculating such Stockholder’s pro rata portion. 

  
 13 

 (d)    Transfers by a Stockholder in connection with the Private
Placement or IPO. 
 (e)    The transfer of equity interests in SLP Geology Aggregator, L.P. which reflect an indirect
interest in not more than 20% of the Shares purchased by the Silver Lake Stockholders in, or at the time of, the IPO. 

Section 3.8    Idea Men Participation. Notwithstanding anything to the contrary herein, in the event that any
Idea Men Stockholder declines or is otherwise unable to participate in any Transfer proposed by another Stockholder pursuant to Section 3.2, 3.3 or 3.4 as a result of such Idea Men Stockholder or any of its
principals, managing members or affiliates (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) being subject to trading restrictions under the Issuer’s insider trading policy, determined in good faith by such Idea
Men Stockholder to be in possession of material non-public information, or for any other reason, the Idea Men Stockholders shall have the right, but not the obligation, to include the Idea Men
Stockholders’ pro rata portion of Shares not so transferred (the “Catch-Up Shares“) in any future Rule 144 Transfer pursuant to Section 3.4. To the extent the
Idea Men Stockholder elects to include any Catch-up Shares in a future Rule 144 Transfer, the shares of the Stockholders that are to be included in such Rule 144 Transfer shall be allocated as follows: first,
to Idea Men up to the amount of Catch-up Shares elected to include in such Rule 144 Transfer; and second, among all the Stockholders (including Idea Men) based on their Rule 144 Pro Rata Portion (which, in the
case of Idea Men, shall disregard any Catch-up Shares) of the remaining Shares, if any, in accordance with Section 3.4. 

Section 3.9    Termination of Article III. The restrictions set forth in this Article III with respect to any
Stockholder shall be of no further effect with respect to the Shares as of the earlier of (i) the completion of the Transfer Restriction Period and (ii) provided that such Stockholder does not have a Director Designee on the Board, the
time at which such Stockholder and its Affiliates Beneficially Owns less than 5% of the shares of Common Stock outstanding. 
 ARTICLE IV

 ADDITIONAL AGREEMENTS OF THE PARTIES 

Section 4.1    Exculpation Among Stockholders. Each Stockholder acknowledges that it is not relying upon any
person, firm or corporation, other than the public information filed by the Issuer with the SEC relating to its Shares, in making its investment or decision to sell, retain or further invest in the Issuer. Each Stockholder agrees that none of the
Stockholders or the respective controlling persons, officers, directors, partners, agents, or employees of any Stockholder shall be liable to any other Stockholder for any action heretofore or hereafter taken or omitted to be taken by any of them in
connection with the purchase of the Shares. 
 Section 4.2    Confidentiality. Each Stockholder agrees, for
so long as such Stockholder owns any Shares and for a period of two (2) years following the date upon which such Stockholder ceases to own any Shares, to keep confidential, any non-public information
provided to such Stockholder by the Issuer; provided, however, that nothing herein will limit the disclosure of any 

  
 14 

 
information (i) to the extent required by law, statute, rule, regulation, judicial process, subpoena or court order or required by any governmental agency or other regulatory authority
(including, without limitation, by deposition, interrogatory, request for documents, oral questions, subpoena, civil investigative demand, administrative proceeding or similar process); (ii) that is in the public domain or becomes generally
available to the public, in each case, other than as a result of the disclosure by the parties in violation of this Agreement; (iii) is or becomes available on a non-confidential basis to a Stockholder
from a source other than the Issuer; provided that such source is not subject to any obligation of confidentiality to Issuer; (iv) is independently developed by Stockholder without violating this Agreement (v) to a
Stockholder’s advisors, representatives and Affiliates (which for the Silver Lake Stockholders, Francisco Partners Stockholders and the Spectrum Stockholders shall include, directors, officers, employees, agents, financing sources and direct
and indirect, current and prospective limited partners and investors in the ordinary course of their business); provided that such advisors, representatives and Affiliates shall have been advised of this Agreement and shall have been directed
to comply with the confidentiality provisions hereof, or shall otherwise be bound by customary obligations of confidentiality, and the applicable Stockholder shall be responsible for any breach of or failure to comply with the provisions of this
Section 4.2 applicable to Affiliates who receive confidential information about the Issuer from such Stockholder ; or (vi) to any prospective purchaser of a Stockholder’s Shares; provided that (A) such prospective
purchaser shall have been advised of this Agreement and shall have expressly agreed to be bound by the confidentiality provisions hereof, (B) such prospective purchaser is not an Issuer Competitor or a Person who controls any Issuer Competitor,
and (C) the prospective purchaser shall be responsible for any breach of or failure to comply with this Agreement by any of its Affiliates and such prospective purchaser agrees, at its sole expense, to take reasonable measures (including but
not limited to court proceedings) to restrain its advisors, representatives and Affiliates from prohibited or unauthorized disclosure or use of any confidential information. 

ARTICLE V 
 ADDITIONAL
PARTIES 
 Section 5.1    Additional Parties. Additional parties, provided they are Permitted Holders,
may be added to and be bound by and receive the benefits afforded by this Agreement upon the signing and delivery of a joinder to this Agreement substantially in the form attached as Exhibit A hereto (the “Joinder
Agreement”) by the Issuer and the acceptance thereof by such additional parties and, to the extent permitted by Section 6.1, amendments may be effected to this Agreement reflecting such rights and obligations,
consistent with the terms of this Agreement, of such party as the Issuer, the Stockholders and such party may agree. 
 ARTICLE VI

 MISCELLANEOUS 

Section 6.1    Amendment. The terms and provisions of this Agreement may be modified or amended at any time
and from time to time only by the written consent of each party hereto; provided that the consent of any party for whom the provisions of Article III have terminated pursuant to Section 3.9 shall not be required for
any amendment to Article III. 
 Section 6.2    Corporate Opportunities. Each Stockholder hereby represents,
warrants and covenants to the Issuer and each other Stockholder that such Stockholder (i) understands that 

  
 15 

 
Article XI of the Amended and Restated Certificate of Incorporation includes provisions that provide that the Issuer, to the fullest extent permitted by law and in accordance with
Section 122(17) of the General Corporation Law of the State of Delaware, renounce any interest or expectancy in certain corporate opportunities that are presented to the parties hereto, subject to certain exceptions, and (ii) shall not
vote in favor of amending, or otherwise seek to amend, Article XI of the Issuer’s Amended and Restated Certificate of Incorporation without the written consent of each Stockholder that is a then-current Stockholder under the terms of this
Agreement. In addition, the Issuer hereby agrees that it shall not seek to amend or remove Article XI of the Amended and Restated Certificate of Incorporation in a manner adverse to any then-current Stockholder under the terms of this Agreement
without the prior consent of such adversely effected Stockholder(s). 
 Section 6.3    Termination. This
Agreement shall automatically terminate upon the earlier of (i) a Change in Control; (ii) written agreement of each Stockholder who holds Shares at such time; or (iii) solely with respect to a particular Stockholder, the dissolution
or liquidation of such Stockholder. In the event of any termination of this Agreement as provided in clauses (i) or (ii) of this Section 6.3, this Agreement shall forthwith become wholly void and of no further force or
effect (except for this Article VI) and there shall be no liability on the part of any parties hereto or their respective officers or directors, except as provided in this Article VI.
Notwithstanding the foregoing, no party hereto shall be relieved from liability for any willful breach of this Agreement. 

Section 6.4    Non-Recourse. Notwithstanding anything that may be
expressed or implied in this Agreement or any document or instrument delivered in connection herewith, and notwithstanding the fact that certain of the Stockholders may be partnerships or limited liability companies, by its acceptance of the
benefits of this Agreement, the Issuer and each Stockholder covenant, agree and acknowledge that no Person (other than the parties hereto) has any obligations hereunder, and that, to the fullest extent permitted by law, no recourse under this
Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or future director, officer, employee, general or limited partner or member of any Stockholder or of any Affiliate or assignee
thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable Law, it being expressly agreed and acknowledged that no personal liability whatsoever shall
attach to, be imposed on or otherwise be incurred by any the former, current and future equity holders, controlling persons, directors, officers, employees, agents, affiliates, members, managers, general or limited partners or assignees of the
Stockholders or any former, current or future stockholder, controlling person, director, officer, employee, general or limited partner, member, manager, Affiliate, agent or assignee of any of the foregoing, as such for any obligation of any
Stockholder under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or their creation. 

Section 6.5    No Third Party Beneficiaries. This Agreement shall be binding upon and inure solely to the
benefit of the parties hereto and their permitted assigns and successors, and, except as provided in Section 6.4, nothing herein, express or implied, is intended to or shall confer upon any other Person or entity, any legal
or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. 

  
 16 

 Section 6.6    Recapitalizations; Exchanges, Etc. The
provisions of this Agreement shall apply to the full extent set forth herein with respect to Shares, to any and all shares of capital stock of the Issuer or any successor or assign of the Issuer (whether by merger, consolidation, sale of assets or
otherwise) which may be issued in respect of, in exchange for, or in substitution of the Shares, by reason of a stock dividend, stock split, stock issuance, reverse stock split, combination, recapitalization, reclassification, merger, consolidation
or otherwise. 
 Section 6.7    Addresses and Notices. Any notice provided for in this Agreement will be in
writing and will be either personally delivered, or received by certified mail, return receipt requested, sent by reputable overnight courier service (charges prepaid) or facsimile or electronic mail to the Issuer at the address set forth below and
to any other recipient and to any holder of Shares at such address as indicated by the Issuer’s records, or at such address or to the attention of such other person as the recipient party has specified by prior written notice to the sending
party. Notices will be deemed to have been given hereunder when delivered personally or sent by electronic mail (provided confirmation of such electronic mail is received or such electronic mail is delivered during regular business hours on any
Business Day to the respective email addresses below and no bounce-back or error message is received by the sender), three days after deposit in the U.S. mail and one day after deposit with a reputable overnight courier service. If notice is given
to the Issuer or to the Stockholders, a copy shall be sent to such party at the addresses set forth below: 
  

	 	(v)	 if to the Issuer, to: 

GoodRx Holdings, Inc. 
 233
Wilshire Blvd., Suite 900 
 Santa Monica, CA 90401 

Attention: Karsten Voermann; Gracye Cheng 

with a copy (which shall not constitute written notice) to: 

Latham & Watkins LLP 

885 Third Avenue 
 New York, NY
10022 
 Attention: Marc Jaffe; Ben Cohen 

with a copy (which shall not constitute notice) to each of the Silver Lake Stockholders, the Francisco Partners Stockholders, the Spectrum
Stockholders and the Idea Men Stockholders as specified in sub-parts (x) and (y) below; 
  

	 	(w)	 if to the Silver Lake Stockholder, to: 

Silver Lake 
 55 Hudson Yards

 550 West 34th Street, 40th Floor 

New York, NY 10001 

  
 17 

 Attention: Andrew J. Schader 

with a copy (which shall not constitute written notice) to: 

Ropes & Gray LLP 

Three Embarcadero Center 
 San
Francisco, CA 94111-4006 
 Attention: Thomas Holden and Eric Issadore 

 

	 	(x)	 if to the Francisco Partners Stockholders, to: 

Francisco Partners 
 One
Letterman Drive 
 Building C - Suite 410 

San Francisco, CA 94129 

Attention: Chris Adams or Steve Eisner 
  

	 	(y)	 if to the Spectrum Stockholders, to: 

Spectrum Equity 
 140 New
Montgomery St., 20th Floor 
 San Francisco, CA 94105 

Attention: Stephen LeSieur 

(z)    if to the Idea Men Stockholders, to: 

Idea Men 
 8605 Santa Monica
Blvd., Ste 30736 
 West Hollywood, CA 90069-4109 

Attention: Trevor Bezdek 

Section 6.8    Binding Effect. This Agreement shall be binding upon and inure to the benefit of the parties
hereto and their heirs, executors, administrators, successors, legal representatives and permitted assigns. 

Section 6.9    Waiver. No failure by any party to insist upon the strict performance of any covenant, duty,
agreement or condition of this Agreement or to exercise any right or remedy consequent upon a breach thereof shall constitute a waiver of any such breach or any other covenant, duty, agreement or condition. 

Section 6.10    Counterparts. This Agreement may be executed in separate counterparts, each of which will be
an original and all of which together shall constitute one and the same agreement binding on all the parties hereto. 

  
 18 

 Section 6.11    Applicable Law; Waiver of Jury Trial. This
Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that
would cause the application of the laws of any jurisdiction other than the State of Delaware. The parties hereto agree that any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection
with, this Agreement or the transactions contemplated hereby (whether brought by any party or any of its Affiliates or against any party or any of its Affiliates) shall be brought in the Court of Chancery of the State of Delaware (or in the event,
but only in the event, that such court does not have subject matter jurisdiction over such action or proceeding, the Superior Court of the State of Delaware (Complex Commercial Division) or, if subject matter jurisdiction over the action or
proceeding is vested exclusively in the federal courts of the United States of America, the United States District Court for the District of Delaware) and each of the parties hereby irrevocably consents to the jurisdiction of such courts (and of the
appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or
proceeding in any such court or that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be served on any party anywhere in the world, whether
within or without the jurisdiction of any such court. THE PARTIES HERETO HEREBY IRREVOCABLY WAIVE ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

Section 6.12    Severability. Whenever possible, each provision of this Agreement will be interpreted in such
manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or
unenforceability will not affect any other provision or the effectiveness or validity of any provision in any other jurisdiction, and this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or
unenforceable provision had never been contained herein. 
 Section 6.13    Delivery by Facsimile. This
Agreement and any signed agreement or instrument entered into in connection with this Agreement or contemplated hereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine or electronic
transmission (i.e., in portable document format), shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof
delivered in person. At the request of any party hereto or to any such agreement or instrument, each other party hereto or thereto shall re-execute original forms thereof and deliver them to all other parties.
No party hereto or to any such agreement or instrument shall raise the use of a facsimile machine or electronic transmission to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the
use of a facsimile machine or electronic transmission as a defense to the formation of a contract and each such party forever waives any such defense. 

Section 6.14    Entire Agreement. This Agreement, together with the Investor Rights Agreement, and all of the
other exhibits, annexes and schedules hereto and thereto constitute the entire understanding and agreement between the parties as to restrictions on the transferability of 

  
 19 

 
Shares and the other matters covered herein and therein and supersede and replace any prior understanding, agreement between the parties as to restrictions on the transferability of Shares and
the other matters covered herein and therein and supersede and replace any prior understanding, agreement or statement of intent, in each case, written or oral, of any and every nature with respect thereto. In the event of any inconsistency between
this Agreement and any agreement executed or delivered to effect the purposes of this Agreement, this Agreement shall govern as among the parties hereto. 

Section 6.15    Remedies. The Issuer and the Stockholders shall be entitled to enforce their rights under this
Agreement specifically, to recover damages by reason of any breach of any provision of this Agreement (including, without limitation, costs of enforcement) and to exercise all other rights existing in their favor. The parties hereto agree and
acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this Agreement, and that the Issuer or any Stockholder may in its sole discretion apply to any court of law or equity of competent jurisdiction for
specific performance or injunctive relief (without posting a bond or other security) in order to enforce or prevent any violation of the provisions of this Agreement. All remedies, either under this Agreement or by Law or otherwise afforded to any
party, shall be cumulative and not alternative. All obligations hereunder shall be satisfied in full without set-off, defense or counterclaim. 

Section 6.16    Settlement. The Issuer hereby agrees that it shall use commercially reasonable efforts to
effect the settlement of any conversion of Class B Common Stock to Class A Common Stock within two (2) Business Days following the receipt of notice from the Stockholder that is the subject of such conversion. 

[The remainder of this page intentionally left blank] 

  
 20 

 IN WITNESS WHEREOF, each of the undersigned has executed this Agreement or caused this
Agreement to be executed on its behalf as of the date first written above. 
  

			
	COMPANY:
	
	GOODRX HOLDINGS, INC.

 
			
		
	By:	 	  

 
			
	Name:
	Title:

  
 [Signature Page to
Exchange Agreement] 

 
	
	STOCKHOLDERS:
	
	SLP GEOLOGY AGGREGATOR, L.P.
	
	By: SLP Geology GP, L.L.C., its general partner
	
	By: Silver Lake Technology Associates V, L.P., its managing member
	
	By: SLTA V (GP), L.L.C., its general partner
	
	By: Silver Lake Group, L.L.C., its managing member
	
	     

	Name:
	Title:

  
 [Signature Page to
GoodRx Holdings, Inc. Stockholders Agreement] 

 
	
	FRANCISCO PARTNERS IV, L.P.
	
	By: Francisco Partners GP IV, L.P.
	Its: General partner
	
	By: Francisco Partners GP IV Management Limited
	Its: General partner
	
	     

	Name:
	Title:
	
	FRANCISCO PARTNERS IV-A, L.P.
	
	By: Francisco Partners GP IV, L.P.
	Its: General partner
	
	By: Francisco Partners GP IV Management Limited
	Its: General partner
	
	     

	Name:
	Title:

  
 [Signature Page to
GoodRx Holdings, Inc. Stockholders Agreement] 

 
	
	SPECTRUM VII INVESTMENT MANAGERS’ FUND, L.P.
	
	By: SEA VII Management, LLC,
	Its: General partner
	
	     

	Name:
	Title:
	
	SPECTRUM VII CO-INVESTMENT FUND, L.P.
	
	By: SEA VII Management, LLC,
	Its: General partner
	
	     

	Name:
	Title:

  
 [Signature Page to
GoodRx Holdings, Inc. Stockholders Agreement] 

 
	
	SPECTRUM EQUITY VII, L.P.
	
	By: Spectrum Equity Associates VII, L.P.,
	Its: General partner
	
	By: SEA VII Management, LLC,
	Its: General partner
	
	     

	Name:
	Title:

  
 [Signature Page to
GoodRx Holdings, Inc. Stockholders Agreement] 

 
	
	IDEA MEN, LLC
	
	     

	Name:
	Title:

  
 [Signature Page to
GoodRx Holdings, Inc. Stockholders Agreement] 

 EXHIBIT A 

FORM OF JOINDER TO STOCKHOLDERS’ AGREEMENT 

This Joinder Agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned (the
“Joining Party”) in accordance with the Stockholders’ Agreement dated as of [                    ,] 2020 (the
“Stockholders’ Agreement”) among GoodRx Holdings, Inc. and certain other persons named therein, as the same may be amended from time to time. Capitalized terms used, but not defined, herein shall have the meaning ascribed to
such terms in the Stockholders’ Agreement. 
 The Joining Party hereby acknowledges, agrees and confirms that, by its execution of this
Joinder Agreement, the Joining Party shall be deemed to be a party to and a “Stockholder” under the Stockholders’ Agreement as of the date hereof and shall have all of the rights and obligations of the Stockholder from whom it
has acquired Shares (to the extent permitted by the Stockholders’ Agreement) as if it had executed the Stockholders’ Agreement. The Joining Party hereby ratifies, as of the date hereof, and agrees to be bound by, all of the terms,
provisions and conditions contained in the Stockholders’ Agreement. 
 IN WITNESS WHEREOF, the undersigned has executed this Joinder
Agreement as of the date written below. 
 Date:
                             [●], 20[●] 

 

			
	 [NAME OF JOINING
PARTY]

 
			
		
	By:	 	  

 
			
	 Name:
	 	
	 Title:
	 	
	
	 Address for Notices:

 AGREED ON THIS [●] day of [●], 20[●]: 

 EXHIBIT B 

FORM OF DIRECTOR & OFFICER INDEMNIFICATION AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]